In SAM et al. v. Kennedy (1:26-cv-01081), the Court Weighs Whether CMS Overstepped Its Authority by allowing Hemp, Marijuana Cannabinoid Access Without FDA Approval. Duane Boise, CEO of MMJ ...
The Centers for Medicare & Medicaid Services will provide eligible Medicare beneficiaries monthly access to certain GLP-1 medications for $50 per month beginning July 1, 2026, through December 31, ...
A GLP-1 Bridge pilot program launching in July can significantly reduce the price you pay for weight loss meds. Here’s how to ...
The BALANCE program was intended to cover weight-loss drugs for Medicaid beneficiaries, but is delayed. A new solution with some downsides takes its place.
Centers for Medicare and Medicaid Services COO Kim Brandt talked about her agency’s use cases for artificial intelligence in the ongoing battle against fraudulent medical claims. The Centers for ...
The Centers for Medicare and Medicaid Services recently announced negotiated prices for 15 drugs, finalizing the second iteration of the Medicare Drug Price Negotiation Program. The first set of ...
On April 23, 2026, the Food and Drug Administration (FDA) and Centers for Medicare & Medicaid Services (CMS) jointly announced the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results